SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC
Clinical trial NCT05583409 · UNKNOWN
Trial details
- NCT number
- NCT05583409
- Sponsor
- Li Zhang
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2024-12-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.